Published in Proteomics on March 01, 2008
Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci (2009) 5.53
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway. Oncotarget (2014) 1.08
Oxidative stress: Biomarkers and novel therapeutic pathways. Exp Gerontol (2010) 1.04
The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression. Oncogene (2010) 1.03
Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways. Oxid Med Cell Longev (2010) 0.98
New strategies for Alzheimer's disease and cognitive impairment. Oxid Med Cell Longev (2010) 0.98
A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity. PLoS One (2013) 0.94
Diabetes mellitus: channeling care through cellular discovery. Curr Neurovasc Res (2010) 0.93
Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology. ScientificWorldJournal (2009) 0.90
CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis. Mol Ther (2010) 0.90
Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis. Endocrinology (2010) 0.86
Novel avenues of drug discovery and biomarkers for diabetes mellitus. J Clin Pharmacol (2010) 0.86
PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury. Neurosci Lett (2014) 0.84
Signaling mechanisms regulating myelination in the central nervous system. Neurosci Bull (2013) 0.83
Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis. Mult Scler Int (2011) 0.79
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination. Mediators Inflamm (2013) 0.77
Leukemia inhibitor factor promotes functional recovery and oligodendrocyte survival in rat models of focal ischemia. Eur J Neurosci (2014) 0.76
A functional interplay between 5-lipoxygenase and μ-calpain affects survival and cytokine profile of human Jurkat T lymphocyte exposed to simulated microgravity. Biomed Res Int (2014) 0.75
The genome of the kinetoplastid parasite, Leishmania major. Science (2005) 8.64
Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab (2010) 2.33
The genome of bacteriophage phiKZ of Pseudomonas aeruginosa. J Mol Biol (2002) 2.09
Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells (2005) 1.85
Pathogenic features of CD4+CD28- T cells in immune disorders. Trends Mol Med (2012) 1.80
The genome of bacteriophage phiKMV, a T7-like virus infecting Pseudomonas aeruginosa. Virology (2003) 1.79
Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the phiKMV subgroup within the T7 supergroup. J Bacteriol (2006) 1.72
Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J Neurosci Res (2006) 1.60
Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci (2010) 1.57
In vitro-differentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymus. Blood (2009) 1.56
T4-related bacteriophage LIMEstone isolates for the control of soft rot on potato caused by 'Dickeya solani'. PLoS One (2012) 1.52
The physiologic effects of caloric restriction are reflected in the in vivo adipocyte-enriched proteome of overweight/obese subjects. J Proteome Res (2009) 1.51
The structural proteome of Pseudomonas aeruginosa bacteriophage phiKMV. Microbiology (2006) 1.50
Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol (2008) 1.47
Reelin signaling directly affects radial glia morphology and biochemical maturation. Development (2003) 1.44
Comparative analysis of the widespread and conserved PB1-like viruses infecting Pseudomonas aeruginosa. Environ Microbiol (2009) 1.39
A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods (2007) 1.38
CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J Immunol (2007) 1.37
The genome and structural proteome of YuA, a new Pseudomonas aeruginosa phage resembling M6. J Bacteriol (2007) 1.31
Molecular and physiological analysis of three Pseudomonas aeruginosa phages belonging to the "N4-like viruses". Virology (2010) 1.30
The T7-related Pseudomonas putida phage φ15 displays virion-associated biofilm degradation properties. PLoS One (2011) 1.25
Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J Neurosci Res (2004) 1.23
Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol Med (2010) 1.21
A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathog (2008) 1.19
Survey of Pseudomonas aeruginosa and its phages: de novo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses. Environ Microbiol (2009) 1.15
Genome comparison of Pseudomonas aeruginosa large phages. J Mol Biol (2005) 1.14
Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators Inflamm (2013) 1.14
Localization of the lipopolysaccharide recognition complex in the human healthy and inflamed premature and adult gut. Inflamm Bowel Dis (2010) 1.11
Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. Eur J Pharmacol (2003) 1.10
A three-dimensional cryo-electron microscopy structure of the bacteriophage phiKZ head. J Mol Biol (2005) 1.10
Microbial endoxylanases: effective weapons to breach the plant cell-wall barrier or, rather, triggers of plant defense systems? Mol Plant Microbe Interact (2006) 1.10
The intron-containing genome of the lytic Pseudomonas phage LUZ24 resembles the temperate phage PaP3. Virology (2008) 1.08
Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res Bull (2005) 1.08
Identification of novel human adipocyte secreted proteins by using SGBS cells. J Proteome Res (2010) 1.08
Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics (2004) 1.06
Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus. PLoS One (2011) 1.05
CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients. J Autoimmun (2011) 1.05
From dormant to germinating spores of Streptomyces coelicolor A3(2): new perspectives from the crp null mutant. J Proteome Res (2005) 1.05
Treatment of missing values for multivariate statistical analysis of gel-based proteomics data. Proteomics (2008) 1.05
Update in the methodology of the chronic stress paradigm: internal control matters. Behav Brain Funct (2011) 1.05
Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathol (2014) 1.05
Insights into the immunopathogenesis of multiple sclerosis. Immunol Res (2002) 1.03
Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol (2007) 1.03
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics (2006) 1.02
Properties of TAXI-type endoxylanase inhibitors. Biochim Biophys Acta (2004) 1.02
Effects of long-term resistance training and simultaneous electro-stimulation on muscle strength and functional mobility in multiple sclerosis. Mult Scler (2010) 1.01
Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Ann N Y Acad Sci (2005) 0.99
Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell Mol Life Sci (2012) 0.99
Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun (2010) 0.98
Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol (2008) 0.97
Proteomics of life at low temperatures: trigger factor is the primary chaperone in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125. Mol Microbiol (2010) 0.96
Romulus and Remus, two phage isolates representing a distinct clade within the Twortlikevirus genus, display suitable properties for phage therapy applications. J Virol (2013) 0.95
Recombinant expression and characterization of XynD from Bacillus subtilis subsp. subtilis ATCC 6051: a GH 43 arabinoxylan arabinofuranohydrolase. Appl Microbiol Biotechnol (2007) 0.95
Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry. J Proteome Res (2006) 0.95
Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep. J Neuroinflammation (2013) 0.94
Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4. BMC Neurosci (2004) 0.94
The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. J Proteome Res (2009) 0.93
Identification and comparative analysis of the structural proteomes of phiKZ and EL, two giant Pseudomonas aeruginosa bacteriophages. Proteomics (2009) 0.92
Occurrence of proteinaceous endoxylanase inhibitors in cereals. Biochim Biophys Acta (2004) 0.92
Which immune cells matter? The immunopathogenesis of multiple sclerosis. Crit Rev Immunol (2013) 0.92
Immunoregulation of autoimmunity by natural killer T cells. Hum Immunol (2006) 0.92
Proteomic and functional characterization of a Chlamydomonas reinhardtii mutant lacking the mitochondrial alternative oxidase 1. J Proteome Res (2010) 0.91
CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis. Mol Ther (2010) 0.90
Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging. J Neuroimmunol (2008) 0.90
The auto-antigen repertoire in myasthenia gravis. Autoimmunity (2010) 0.90
Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity. J Neuroimmunol (2002) 0.89
Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation. Blood (2011) 0.89
Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis. J Neurosci Res (2006) 0.88
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls. J Rheumatol (2004) 0.88
Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS One (2013) 0.88
Expression and functional characterization of the first bacteriophage-encoded chaperonin. J Virol (2012) 0.87
Arginine deficiency in preconfluent intestinal Caco-2 cells modulates expression of proteins involved in proliferation, apoptosis, and heat shock response. Proteomics (2007) 0.87
Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions. Crit Rev Immunol (2002) 0.87
Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients. Biomark Med (2014) 0.87
Proteomic changes in rat hippocampus and adrenals following short-term sleep deprivation. Proteome Sci (2008) 0.87
Glycine and glycine receptor signalling in non-neuronal cells. Front Mol Neurosci (2009) 0.87